Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000874796 | SCV001017024 | likely benign | CHARGE syndrome | 2023-12-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001548457 | SCV001768373 | likely benign | not provided | 2021-03-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002336844 | SCV002642553 | likely benign | Inborn genetic diseases | 2017-11-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002495308 | SCV002797256 | likely benign | CHARGE syndrome; Hypogonadotropic hypogonadism 5 with or without anosmia | 2022-04-22 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001548457 | SCV004702377 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | CHD7: BP4, BP7 |